Call for Pilot Project Proposals

Call for Pilot Project Proposals

Submission Deadline: February 15, 2024

The Department of Pathology and Laboratory Medicine at the Warren Alpert Medical School of Brown University is calling for proposal for pilot projects. The objective is to stimulate translational research collaborations and provide funding support for clinical faculty in the Brown affiliated hospital systems. Funds are available to support 2-3 projects (maximum of $25,000 per project).


Faculty with employment in the Pathology Department of a Brown Affiliated Hospital are required as the primary applicant (Lifespan, Care New England, or the VA Hospitals).

Must be a joint proposal involving Pathology faculty (campus or hospital based) and/or inter-institutional research. Proposals involving three department sites (Brown, CNE, VA or Lifespan) are strongly encouraged.

One of principal investigators must be at the rank of assistant or associate professor.

The applicants have not received the same Pilot award from previous year.

Application Format:

Two to three-page proposal including:

  • Project Summary (<100 words)
  • Significance/Impact
  • Specific Aims
  • Research Strategies/Approaches
  • Brief Budget (maximum of $25,000; equipment, personnel and travel cost will not be covered)

CV from both Co-PIs

Project Period: April 15, 2024 – April 15, 2025

Reporting Requirements: The pilot project awardees will provide a final progress report to the Committee by July 1, 2025.                      

Application Submission: Applications should be submitted by e-mail to Drs. Liang Cheng [email protected] or Geralyn Lambert-Messerlian [email protected]. The submission deadline is February 15, 2024.                        

Committee Members:

Liang Cheng, MD, MS (Co-Chair)                                                 

Geralyn Lambert-Messerlian, PhD, FAACC (Co-Chair)                                       

Sean Lawler, PhD

M. Ruhul Quddus, MD

Robert W. Sobol, PhD

Dr. Ece Uzun has been Awarded the Designation of Fellow of American Medical Informatics Association (FAMIA)

Dr. Ece Uzun has been awarded the designation of Fellow of AMIA, or FAMIA. This achievement signals to patients, employers, and colleagues that you are an expert in evidence-based informatics practice and engaged with a community of life-long learners who apply the latest advances in informatics to improve health and health care.

Dr. Uzun will be honored along with 84 FAMIA recipients for her contributions to informatics and AMIA at the AMIA 2024 Clinical Informatics Conference , May 21-23, 2024  where she will be formally inducted into the Fellowship of AMIA. Certificates will be presented at the induction.

Dr. Jonathan Kurtis Receives Falk Medical Research Trust Transformational Award

Dr. Jonathan Kurtis, Chair of the Department of Pathology and Laboratory Medicine, has been selected as a 2023 award recipient of the Falk Medical Research Trust Transformational Award. Bank of America Private Bank, serves as Trustee of the Falk Medical Research Trust Transformational Award. The Medical Foundation at Health Resources in Action, Boston, MA (The Medical Foundation) administers the Falk Medical Research Trust Transformational Award on behalf of Bank of America Private Bank.  Dr Kurtis’ project will focus on the discovery and pre-clinical development of novel anti-malarial drugs.

Winner of 2023 Annual Virchows Archiv Prize for the Best Paper Announced!

Congratulations to Professor Liang Cheng and his team for the Virchows Archiv Prize for the Best Paper, announced by the European Society of Pathology on the final day (September 13, 2023) of the 35th European Congress of Pathology in Dublin, Ireland. Dr. Liang Cheng is the senior author of the paper entitled “T1 Bladder Carcinoma with Variant Histology: Pathological Features and Clinical Significance”.    


The Bailey lab led by postdoctoral fellow Abebe Fola publishes article in Nature Microbiology detailing the concerning evolution of malaria resistant to both diagnosis and the front line drug artemisinin in Ethiopia.

Plasmodium falciparum resistant to artemisinin and diagnostics have emerged in Ethiopia

Diagnosis and treatment of Plasmodium falciparum infections are required for effective malaria control and are pre-requisites for malaria elimination efforts; hence we need to monitor emergence, evolution and spread of drug- and diagnostics-resistant parasites. We deep sequenced key drug-resistance mutations and 1,832 SNPs in the parasite genomes of 609 malaria cases collected during a diagnostic-resistance surveillance study in Ethiopia. Please see article below: